267 related articles for article (PubMed ID: 8967094)
1. [Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure].
Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
Wien Klin Wochenschr; 1996; 108(16):505-9. PubMed ID: 8967094
[TBL] [Abstract][Full Text] [Related]
2. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
3. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
[TBL] [Abstract][Full Text] [Related]
5. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
Serra W; Musiari L; Ardissino D; Gherli T; Montanari A
Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure.
Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
Am J Ther; 1997; 4(11-12):389-93. PubMed ID: 10423635
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
[TBL] [Abstract][Full Text] [Related]
9. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
11. Cerebral oxygenation during prostaglandin E1 induced hypotension.
Kadoi Y; Saito S; Kunimoto F; Morita T; Goto F; Kawahara F; Fujita N
Can J Anaesth; 1998 Sep; 45(9):860-4. PubMed ID: 9818109
[TBL] [Abstract][Full Text] [Related]
12. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
13. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.
Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B
Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxyethyl starch resuscitation on extravascular lung water and pulmonary permeability in sepsis-related acute respiratory distress syndrome.
Huang CC; Kao KC; Hsu KH; Ko HW; Li LF; Hsieh MJ; Tsai YH
Crit Care Med; 2009 Jun; 37(6):1948-55. PubMed ID: 19384203
[TBL] [Abstract][Full Text] [Related]
15. [Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction].
Koch JA; Sketch M; Brinker J; Bernink PJ
Rofo; 1999 Jun; 170(6):557-63. PubMed ID: 10420905
[TBL] [Abstract][Full Text] [Related]
16. [The course of extravascular lung water in severely injured patients in intensive care with and without thoracic trauma].
Mutz N; Neumann M; Hörmann C; Koller W; Putensen C; Putz G; Benzer H
Anaesthesist; 1990 Oct; 39(10):535-9. PubMed ID: 2278374
[TBL] [Abstract][Full Text] [Related]
17. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
Okuda M; Faruhashi K; Konishi K; Muneyuki M
Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
[TBL] [Abstract][Full Text] [Related]
18. [Extravascular lung water in patients after cardiac surgery].
Iha K; Koja K; Kuniyoshi Y; Akasaki M; Miyagi K; Shinya E; Ohmine Y; Shiroma H; Kina M; Kusaba A
Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):389-95. PubMed ID: 8478565
[TBL] [Abstract][Full Text] [Related]
19. Effect of pulmonary artery pressure on extravascular lung water in an experimental model of acute lung injury.
Colmenero M; Pérez Villares JM; Fernández Sacristán MA; Garcia Delgado M; Fernández Mondéjar E
Acta Anaesthesiol Scand; 2005 Nov; 49(10):1449-55. PubMed ID: 16223388
[TBL] [Abstract][Full Text] [Related]
20. [A study of changes in extravascular lung water after extracorporeal circulation--clinical and experimental studies of decremental factors].
Kuniyoshi Y
Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):209-18. PubMed ID: 1593160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
